• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

激发后胰岛素浓度有助于在无已知糖尿病的受试者中鉴别冠状动脉疾病和心脏X综合征。

Post-challenge insulin concentration is useful for differentiating between coronary artery disease and cardiac syndrome X in subjects without known diabetes mellitus.

作者信息

Liang Kae-Woei, Sheu Wayne H-H, Lee Wen-Jane, Lee Wen-Lieng, Pan Hung-Chih, Lee I-Te, Wang Jun-Sing

机构信息

Cardiovascular Center, Taichung Veterans General Hospital, 1650 Taiwan Boulevard, Sec. 4, Taichung, 40705 Taiwan.

School of Medicine, National Yang Ming University, Taipei, Taiwan.

出版信息

Diabetol Metab Syndr. 2017 Feb 8;9:10. doi: 10.1186/s13098-017-0209-1. eCollection 2017.

DOI:10.1186/s13098-017-0209-1
PMID:28194232
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5299675/
Abstract

BACKGROUND

Cardiac syndrome X (CSX) is characterized by angina pectoris but with patent coronary arteries. Our previous study demonstrated that subjects with CSX had a higher fasting insulin-resistance (IR) than the controls. However, few studies have investigated the degree of IR, including oral glucose tolerance test (OGTT)-derived indices and profiles of metabolic abnormalities between CSX and coronary artery disease (CAD).

METHODS

Ninety-two CSX and 145 CAD subjects without known diabetes mellitus (DM) underwent coronary angiogram (CAG) for angina pectoris and also agreed to receive OGTT and glycated hemoglobin (HbA) evaluations for screening abnormal glucose regulation and IR.

RESULTS

CAD group had more subjects with metabolically unhealthy obesity (52.4 vs. 31.5%, p < 0.001) than the CSX group. The CAD group had higher OGTT 2 h glucose and insulin (both p < 0.005) while fasting glucose, insulin and HOMA-IR were similar to those of CSX subjects. In the binary regression analysis, OGTT 2 h insulin and being metabolic unhealthy were significantly different between the CAD and CSX groups, but there were no significant differences in Matsuda index, fasting glucose, insulin, HOMA-IR, or HbA.

CONCLUSIONS

Post challenge OGTT 2 h insulin and being metabolic unhealthy were useful parameters in differentiating between CAD and CSX in subjects without known DM but suffered from angina pectoris and underwent CAG. Different degrees of IR and metabolic abnormalities might be implicated in the pathogenesis of micro vs. macro vascular coronary diseases. NCT01198730 at https://clinicaltrials.gov, Registered Sep. 8, 2010.

摘要

背景

心脏综合征X(CSX)的特征为心绞痛但冠状动脉通畅。我们之前的研究表明,CSX患者的空腹胰岛素抵抗(IR)高于对照组。然而,很少有研究调查CSX与冠状动脉疾病(CAD)之间IR的程度,包括口服葡萄糖耐量试验(OGTT)得出的指标以及代谢异常情况。

方法

92例CSX患者和145例无糖尿病(DM)的CAD患者因心绞痛接受了冠状动脉造影(CAG),并同意接受OGTT和糖化血红蛋白(HbA)评估以筛查异常葡萄糖调节和IR。

结果

CAD组代谢不健康肥胖的患者比CSX组更多(52.4%对31.5%,p<0.001)。CAD组的OGTT 2小时血糖和胰岛素水平更高(均p<0.005),而空腹血糖、胰岛素和稳态模型评估胰岛素抵抗(HOMA-IR)与CSX患者相似。在二元回归分析中,CAD组和CSX组之间OGTT 2小时胰岛素和代谢不健康情况存在显著差异,但在松田指数、空腹血糖、胰岛素、HOMA-IR或HbA方面无显著差异。

结论

在无已知DM但有心绞痛且接受CAG的患者中,OGTT激发后2小时胰岛素和代谢不健康情况是区分CAD和CSX的有用参数。不同程度的IR和代谢异常可能与微血管和大血管冠状动脉疾病的发病机制有关。https://clinicaltrials.gov上的NCT01198730,于2010年9月8日注册。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f57c/5299675/f2831d282ad4/13098_2017_209_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f57c/5299675/f2831d282ad4/13098_2017_209_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f57c/5299675/f2831d282ad4/13098_2017_209_Fig1_HTML.jpg

相似文献

1
Post-challenge insulin concentration is useful for differentiating between coronary artery disease and cardiac syndrome X in subjects without known diabetes mellitus.激发后胰岛素浓度有助于在无已知糖尿病的受试者中鉴别冠状动脉疾病和心脏X综合征。
Diabetol Metab Syndr. 2017 Feb 8;9:10. doi: 10.1186/s13098-017-0209-1. eCollection 2017.
2
Circulating adipokines and insulin resistance in subjects with combined cardiac and metabolic syndrome X.合并心脏和代谢综合征X患者的循环脂肪因子与胰岛素抵抗
Diabetol Metab Syndr. 2015 Sep 24;7:83. doi: 10.1186/s13098-015-0078-4. eCollection 2015.
3
Endothelial and metabolic characteristics of patients with angina and angiographically normal coronary arteries: comparison with subjects with insulin resistance syndrome and normal controls.心绞痛且冠状动脉造影正常患者的内皮及代谢特征:与胰岛素抵抗综合征患者及正常对照者的比较
J Am Coll Cardiol. 1999 Nov 1;34(5):1452-60. doi: 10.1016/s0735-1097(99)00379-4.
4
Differential expression of circulating vascular cell adhesion molecule-1 in subjects with coronary artery disease and cardiac syndrome X without known diabetes mellitus.循环血管细胞黏附分子-1在无已知糖尿病的冠心病和心脏综合征X患者中的差异表达。
Biomarkers. 2017 Dec;22(8):798-804. doi: 10.1080/1354750X.2017.1351003. Epub 2017 Jul 18.
5
HOMA-IR is associated with significant angiographic coronary artery disease in non-diabetic, non-obese individuals: a cross-sectional study.一项横断面研究表明:在非糖尿病、非肥胖个体中,胰岛素抵抗指数(HOMA-IR)与显著的冠状动脉造影疾病相关。
Diabetol Metab Syndr. 2015 Nov 14;7:100. doi: 10.1186/s13098-015-0085-5. eCollection 2015.
6
Insulin resistance and fasting hyperinsulinemia are risk factors for new cardiovascular events in patients with prior coronary artery disease and normal glucose tolerance.胰岛素抵抗和空腹高胰岛素血症是既往有冠状动脉疾病且糖耐量正常患者发生新发心血管事件的危险因素。
Circ J. 2004 Jan;68(1):47-52. doi: 10.1253/circj.68.47.
7
Assessment of the relationship between red cell distribution width and cardiac syndrome X.红细胞分布宽度与心脏X 综合征关系的评估。
Kardiol Pol. 2013;71(5):480-4. doi: 10.5603/KP.2013.0094.
8
Glucose intolerance, insulin resistance and metabolic syndrome in patients with stable angina pectoris. Obesity predicts coronary atherosclerosis and dysglycemia.稳定型心绞痛患者的葡萄糖耐量异常、胰岛素抵抗和代谢综合征。肥胖预示着冠状动脉粥样硬化和血糖异常。
Pol Arch Med Wewn. 2008 Dec;118(12):719-26.
9
Retinol-binding protein 4 (RBP-4) levels do not change after oral glucose tolerance test and after dexamethasone, but correlate with some indices of insulin resistance in humans.视黄醇结合蛋白4(RBP - 4)水平在口服葡萄糖耐量试验及地塞米松处理后并无变化,但与人类胰岛素抵抗的某些指标相关。
Endokrynol Pol. 2008 Jul-Aug;59(4):305-11.
10
Higher fasting glucose is associated with poorer survival in non-diabetic subjects having ischemia with non-obstructive coronary arteries.空腹血糖水平较高与非糖尿病合并无阻塞性冠状动脉病变患者的预后不良相关。
Sci Rep. 2024 Sep 5;14(1):20681. doi: 10.1038/s41598-024-71796-3.

引用本文的文献

1
Higher fasting glucose is associated with poorer survival in non-diabetic subjects having ischemia with non-obstructive coronary arteries.空腹血糖水平较高与非糖尿病合并无阻塞性冠状动脉病变患者的预后不良相关。
Sci Rep. 2024 Sep 5;14(1):20681. doi: 10.1038/s41598-024-71796-3.
2
Cardiometabolic Risk in Pre- and Post-Menopausal Women with Special Reference to Insulin Resistance: A Cross-Sectional Study.绝经前后女性的心脏代谢风险,特别关注胰岛素抵抗:一项横断面研究。
J Midlife Health. 2020 Jan-Mar;11(1):22-26. doi: 10.4103/jmh.JMH_65_19. Epub 2020 May 4.
3
Increased levels of angiogenic factors in microvascular angina.

本文引用的文献

1
Coronary microvascular dysfunction in patients with cardiac syndrome X: Ongoing debate.心脏X综合征患者的冠状动脉微血管功能障碍:仍在进行的争论。
Int J Cardiol. 2016 Sep 1;218:233-234. doi: 10.1016/j.ijcard.2016.05.050. Epub 2016 May 13.
2
HOMA-IR is associated with significant angiographic coronary artery disease in non-diabetic, non-obese individuals: a cross-sectional study.一项横断面研究表明:在非糖尿病、非肥胖个体中,胰岛素抵抗指数(HOMA-IR)与显著的冠状动脉造影疾病相关。
Diabetol Metab Syndr. 2015 Nov 14;7:100. doi: 10.1186/s13098-015-0085-5. eCollection 2015.
3
Circulating adipokines and insulin resistance in subjects with combined cardiac and metabolic syndrome X.
微血管性心绞痛中血管生成因子水平升高。
Med Pharm Rep. 2019 Jan;92(1):31-35. doi: 10.15386/cjmed-1101. Epub 2019 Jan 15.
4
Two-hour post-challenge hyperglycemia, but not fasting plasma glucose, associated with severity of coronary artery disease in patients with angina.餐后 2 小时高血糖,但不是空腹血糖,与心绞痛患者冠状动脉疾病的严重程度相关。
PLoS One. 2018 Aug 15;13(8):e0202280. doi: 10.1371/journal.pone.0202280. eCollection 2018.
合并心脏和代谢综合征X患者的循环脂肪因子与胰岛素抵抗
Diabetol Metab Syndr. 2015 Sep 24;7:83. doi: 10.1186/s13098-015-0078-4. eCollection 2015.
4
Comparing HbA1c, fasting and 2-h plasma glucose for screening for abnormal glucose regulation in patients undergoing coronary angiography.比较糖化血红蛋白、空腹血糖和餐后2小时血糖用于冠状动脉造影患者异常血糖调节的筛查。
Clin Chem Lab Med. 2015 Aug;53(9):1441-9. doi: 10.1515/cclm-2014-0860.
5
Metabolically-healthy obesity and coronary artery calcification.代谢健康型肥胖与冠状动脉钙化。
J Am Coll Cardiol. 2014 Jun 24;63(24):2679-86. doi: 10.1016/j.jacc.2014.03.042. Epub 2014 Apr 30.
6
Metabolically healthy obesity and the risk of cardiovascular disease and type 2 diabetes: the Whitehall II cohort study.代谢健康型肥胖与心血管疾病及2型糖尿病风险:白厅II队列研究
Eur Heart J. 2015 Mar 1;36(9):551-9. doi: 10.1093/eurheartj/ehu123. Epub 2014 Mar 26.
7
Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications.代谢健康型肥胖:流行病学、机制及临床意义。
Lancet Diabetes Endocrinol. 2013 Oct;1(2):152-62. doi: 10.1016/S2213-8587(13)70062-7. Epub 2013 Aug 30.
8
Association between microvascular angina and erectile dsyfunction.微血管性心绞痛与勃起功能障碍之间的关联。
Int J Impot Res. 2014 Jul-Aug;26(4):124-7. doi: 10.1038/ijir.2013.49. Epub 2013 Dec 19.
9
Insulin resistance and risk of incident cardiovascular events in adults without diabetes: meta-analysis.胰岛素抵抗与无糖尿病成人心血管事件发病风险:荟萃分析。
PLoS One. 2012;7(12):e52036. doi: 10.1371/journal.pone.0052036. Epub 2012 Dec 28.
10
Performance of HbA1c and fasting plasma glucose in screening for diabetes in patients undergoing coronary angiography.糖化血红蛋白和空腹血糖在冠状动脉造影患者糖尿病筛查中的表现。
Diabetes Care. 2013 May;36(5):1138-40. doi: 10.2337/dc12-1434. Epub 2012 Dec 13.